Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits

British Journal of Pharmacology
F GudatA Pletscher

Abstract

1 Nerve growth factor (NGF), substance P (SP) and thymopoietin all caused shape change reactions of rapid onset in rabbit platelets. NGF had the highest maximal effect, and SP the lowest EC50 (concentration causing half maximal shape change). The action of SP was reversible within 5 min, whereas that of NGF lasted for at least 1 h. A series of other peptides were inactive. 2 After preincubation of platelets with SP, a second application of SP no longer caused a shape change reaction, whereas the effect of NGF was not influenced. 3 An oxidized NGF-derivative without biological activity did not cause a shape change reaction, neither did epidermal growth factor. 4 Prostaglandin E1 (PGE1) and pretreatment of the platelets with 3% butanol, which counteract the shape changes caused by 5-hydroxytryptamine (5-HT) and adenosine 3',5'-diphosphate, also antagonized those induced by NGF and SP. Neither heparin nor methysergide, an antagonist of 5-HT-receptors, influenced the shape change induced by NGF or SP. The action of NGF was also antagonized by a specific antibody to NGF. 5 Thymopoietin, like the basic polypeptide polyornithine (mol. wt. 40,000) was not antagonized by PGE1 and butanol. Heparin, which counteracted the effect of polyor...Continue Reading

References

Dec 1, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·A LaubscherJ G Richards
Nov 1, 1979·Acta Endocrinologica·B CzarnockaW Kiełczyński
Apr 1, 1979·British Journal of Pharmacology·M Graf, A Pletscher
Jun 1, 1976·Journal of Neurochemistry·K StoeckelH Thoenen
Jan 1, 1968·Annual Review of Pharmacology·J M Jiménez-Porras
Oct 1, 1969·Proceedings of the National Academy of Sciences of the United States of America·V Bocchini, P U Angeletti
May 23, 1972·European Journal of Biochemistry·I CovelliL Frati
Mar 1, 1970·Experimental Cell Research·E L Fenton

❮ Previous
Next ❯

Citations

Oct 1, 1992·Journal of Neuroscience Research·K MuraseK Hayashi
Feb 15, 1988·Experientia·M Da PradaJ G Richards
Jun 1, 1995·Journal of the Neurological Sciences·R Levi-MontalciniA Leon
Oct 1, 1995·Toxicon : Official Journal of the International Society on Toxinology·T KostizaJ Meier
Jul 1, 1996·Toxicon : Official Journal of the International Society on Toxinology·T Kostiza, J Meier
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·A Rotman
Jun 1, 1995·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·U Otten, R A Gadient
Jan 1, 1993·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M A Barradas, D P Mikhailidis
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·H MatsudaJ A Denburg
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·U OttenR Peck
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·P B EhrhardU Otten
Jan 1, 1994·Journal of Physiology, Paris·P PradierR Romand
Jan 20, 2009·Atherosclerosis·Jonathan M Gibbins
Jul 1, 2008·British Journal of Pharmacology·N E BarrettJ M Gibbins
Feb 23, 1999·The American Journal of Pathology·E LabouyrieJ P Merlio
Feb 26, 2008·Current Opinion in Pharmacology·Sarah Jones, Jonathan M Gibbins
Jan 24, 2006·Cephalalgia : an International Journal of Headache·F BlandiniA Leon
Jun 26, 1999·Microscopy Research and Technique·L AloeF Properzi
Aug 10, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·N KanbeH Matsuda
Dec 1, 1987·Immunological Reviews·R H SteadA M Stanisz
May 8, 2004·Blood·Gwenda J GrahamJonathan M Gibbins
Jan 1, 1988·Immunopharmacology and Immunotoxicology·E G Fischer
Aug 1, 1990·Clinical and Experimental Immunology·M DamonnevilleA Capron
Apr 24, 2002·Pulmonary Pharmacology & Therapeutics·Caroline Olgart Höglund, Nelly Frossard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.